A sunscreen budget connects multiple decisions. Unit price alone hides development, testing, packaging, minimum purchases and schedule risk.
Why this matters in a sunscreen project
A responsible brief aligns performance, user experience, manufacturing, packaging, documentation and market requirements. Commercial statements should only be finalised when the evidence matches the finished product.
Catalogue versus new formula
An available formula can reduce R&D time, while a unique architecture needs prototypes, validation and scale-up. Personalisation can change that route.
Technical and commercial MOQ
Minimums depend on batch size, process loss, packaging, decoration, cartons and raw-material purchases.
Critical path
Prototype approval, component availability, testing, artwork, documentation and production slots have dependencies. Packaging delay can block the batch.
Total launch cost
Include development, samples, testing, product file, components, manufacturing, logistics and stock, separating one-off from recurring costs.
Briefing checklist
- Units per SKU
- Markets and launch date
- Catalogue or custom
- Packaging and decoration
- Claims and test budget
Frequently asked questions
What is OKT GLOBAL's typical MOQ for a new formula?
As a commercial reference, new developments normally start at 2,000 units, subject to format and feasibility.
Is R&D charged separately?
Yes. New development at OKT GLOBAL starts from EUR 1,500 plus VAT per formula, subject to confirmed scope.
Can price be final before packaging is chosen?
Only an estimate; components, decoration, cartons and quantities affect the final cost.
Development and manufacturing with OKT GLOBAL
OKT GLOBAL integrates R&D, quality, regulatory support, packaging, scale-up and manufacturing in Spain under UNE-EN ISO 22716 certified by Bureau Veritas.